Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology [Yahoo! Finance]
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Orexo initiates new study of OX640 in participants with allergic rhinitis [Yahoo! Finance]
Orexo initiates new study of OX640 in participants with allergic rhinitis